Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
2.
Dermatol Ther (Heidelb) ; 8(2): 313-321, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29777447

RESUMO

The association of junctional epidermolysis bullosa with pyloric atresia (JEB-PA) and aplasia cutis congenita (ACC) was described by El Shafie et al. (J Pediatr Surg 14(4):446-449, 1979) and Carmi et al. (Am J Med Genet 11:319-328, 1982). Most patients die in the first weeks of life, and no curative treatment options are available so far. We describe a patient with JEB-PA and ACC (OMIM # 226730) who was treated for extensive areas of ACC by Integra®-Dermal Regeneration Template and split-thickness skin grafting (STSG). Clinically, the dermal template changed into well-vascularized neodermis, and after STSG, full take of the transplants was detected. No infections of the huge ACC areas were seen. Further studies must validate this treatment option in severe and acute cases of JEB-PA with ACC. Based on clinical findings, we postulate that placement of Integra®-Dermal Regeneration Template with STSG could be a new treatment option for patients having JEB-PA with ACC to prevent severe infection, compartment-syndrome-like conditions, and deformities. Based on literature findings, we assume that Integra®-Dermal Regeneration Template with STSG could even be able to prevent new blistering and thereby be a treatment option in cases of ACC and JEB.

3.
J Invest Dermatol ; 125(4): 700-4, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16185268

RESUMO

Mutations in the type VII collagen gene (COL7A1) cause autosomal recessive and autosomal dominant inherited dystrophic epidermolysis bullosa (DEB). We report a family with three individuals who present blistering, scarring, hypo- and hyperpigmentation, and nail dystrophy suggestive for DEB. Whereas father and son carry a 5;13 translocation, the daughter shows a normal karyotype. Segregation analysis revealed that all affected family members inherited the same COL7A1 allele. Mutation analysis disclosed a heterozygous missense mutation, c.6227G > A (p.G2076D), in COL7A1 in all affected individuals. Delineation of the translocation breakpoints showed that the ERBB2IP (erbb2 interacting protein or Erbin) gene is disrupted in 5q13.1 and GPC6 in 13q32. GPC6 encodes glypican 6 belonging to a family of cell surface heparan sulfate proteoglycans. The binding partners of Erbin, BP230 (BPAG1) and the integrin beta4 subunit, both involved in hemidesmosome (HD) function, and the presence of Erbin in HD suggested that it plays a role in establishment and maintenance of cell-basement membrane adhesions. However, loss of function of one ERBB2IP copy or expression of a putative novel ERBB2IP fusion protein did not apparently modulate the DEB phenotype in both translocation patients. Nonetheless, one cannot yet exclude that ERBB2IP is a candidate for human blistering disorders such as epidermolysis bullosa.


Assuntos
Proteínas de Transporte/genética , Colágeno Tipo VII/genética , Epidermólise Bolhosa Distrófica/genética , Translocação Genética , Proteínas Adaptadoras de Transdução de Sinal , Adulto , Criança , Cromossomos Humanos Par 13 , Cromossomos Humanos Par 5 , Pai , Feminino , Glipicanas , Proteoglicanas de Heparan Sulfato/genética , Humanos , Masculino , Pessoa de Meia-Idade , Núcleo Familiar
4.
J Invest Dermatol ; 120(3): 351-5, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12603845

RESUMO

Mal de Meleda is a recessive, transgressive palmoplantar keratoderma for which we previously identified mutations in the gene encoding secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related protein-1 (SLURP-1). In this report we describe two new mutations: (i) a founder mutation, which changes a conserved cysteine residue to tyrosine (C99Y) in a large inbred Tunisian pedigree, and (ii) a signal sequence mutation (W15R), which was homozygous in a German family and heterozygous in a Scottish patient. Four ancestral haplotypes were observed in 69 patients from countries around the Mediterranean basin, and an additional haplotype was found in the German and Scottish patients.


Assuntos
Antígenos Ly/genética , Haplótipos , Ceratodermia Palmar e Plantar/genética , Mutação , Ativador de Plasminogênio Tipo Uroquinase/genética , Idoso , Sequência de Bases/genética , Sequência Conservada/genética , Cisteína , Feminino , Efeito Fundador , Heterozigoto , Homozigoto , Humanos , Lactente , Recém-Nascido , Ceratodermia Palmar e Plantar/patologia , Masculino , Dados de Sequência Molecular , Mutação/genética , Linhagem , Sinais Direcionadores de Proteínas , Tirosina
5.
Ann Med Interne (Paris) ; 153(4): 280-2, 2002 Jun.
Artigo em Francês | MEDLINE | ID: mdl-12218895

RESUMO

INTRODUCTION: Sjögren-Larsson syndrome (SJS) is an autosomal-recessive disorder. Patients suffer from congenital ichtyosis, mental retardation and symmetric spastic paralysis. Ichtyosis is usually pronounced and associated with erythroderma. Neurological manifestations occur usually between 4 and 13 months of age. This genetic disease is due to fatty acid aldehyde dehydrogenase (FALDH) deficiency, leading to an accumulation of long-chain alcohols. The gene has been mapped to chromosome 17. CASE REPORTS: A 52-year-old woman was hospitalized because of a severe erythroderma with ichtyosis. She suffered from epilepsy, spastic diplegia and mental retardation (Little disease has been diagnosed). The association of spastic paraparesia and ichtyosiform erythroderma suggested the diagnosis of SJS. This was confirmed by the very low level of FALDH activity. A 27-year-old patient was hospitalized for the recent onset paraparesia. Erythematous patches were observed on arm pits and buttocks. The diagnosis of SJS was not confirmed by FALDH assay. DISCUSSION: Diagnosis of Sjögren-Larsson syndrome is a very rare disease in France. It is useful to evoke the diagnosis when spastic paraparesia is associated with these unusual cutaneous signs.


Assuntos
Dermatite Esfoliativa/etiologia , Paraparesia Espástica/etiologia , Síndrome de Sjogren-Larsson/complicações , Adulto , Aldeído Oxirredutases/análise , Aldeído Oxirredutases/farmacologia , Diagnóstico Diferencial , Feminino , Humanos , Deficiência Intelectual/etiologia , Pessoa de Meia-Idade , Síndrome de Sjogren-Larsson/patologia
6.
Hum Mol Genet ; 12(8): 925-35, 2003 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-12668616

RESUMO

Kindler syndrome is a rare autosomal-recessive genodermatosis characterized by bullous poikiloderma with photosensitivity. We report the localization to chromosome 20p12.3 by homozygosity mapping and the identification of a new gene, which we propose to name kindlerin. We found four different homozygous mutations in four consanguineous families from North Africa and Senegal; three are expected to lead to premature stop codons and truncated proteins and the fourth involves a splice site. We were unable to identify a mutation in kindlerin in a fifth consanguineous family from Algeria with a similar phenotype and in which the patient was homozygous for the markers in the 20p12.3 interval. The kindlerin protein contains several domains which are shared by a diverse group of peripheral membrane proteins that function as membrane-cytoskeleton linkers: two regions homologous to band 4.1 domain of which one includes a FERM domain with a NPKY sequence motif, and a third region with a PH or pleckstrin homology domain. Kindlerin might be involved in the bidirectional signaling between integrin molecules in the membrane and the cytoskeleton, and could be involved in cell adhesion processes via integrin signaling.


Assuntos
Proteínas Sanguíneas/genética , Fosfoproteínas/genética , Transtornos de Fotossensibilidade/genética , Dermatopatias/genética , Adolescente , Adulto , Linhagem Celular , Criança , Pré-Escolar , Proteínas da Matriz Extracelular/genética , Feminino , Humanos , Masculino , Proteínas de Membrana , Dados de Sequência Molecular , Mutação , Proteínas de Neoplasias , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Síndrome
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA